跳至主要内容
临床试验/IRCT20220521054939N1
IRCT20220521054939N1已完成3 期

Investigating the effect of indomethacin on the clinical outcome of patients with severe non-hemorrhagic traumatic brain injury, a randomized placebo-controlled study

Mazandaran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 70 years(—)
性别
All

入选标准

  • Registration of informed consent of the first degree patient to participate in the study
  • Age 16 to 70 years
  • Severe traumatic brain injury with closed or penetrating mechanism
  • High resistant ICP

排除标准

  • Brain death
  • Coagulation disorders
  • History of gastrointestinal bleeding or active bleeding
  • History of peptic ulcer
  • Acute kidney injury
  • History of allergies to nonsteroidal anti-inflammatory drugs
  • Clinical signs and symptoms of renal failure or its history
  • Hyperkalemia
  • Liver failure

研究者

相似试验